Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Other Working Capital Changes (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Other Working Capital Changes for 7 consecutive years, with -$187000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 60.21% year-over-year to -$187000.0, compared with a TTM value of -$711000.0 through Dec 2025, down 112.61%, and an annual FY2025 reading of -$711000.0, down 112.61% over the prior year.
  • Other Working Capital Changes was -$187000.0 for Q4 2025 at aTYR PHARMA, down from -$183000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $7.6 million in Q1 2024 and bottomed at -$8.0 million in Q2 2024.
  • Average Other Working Capital Changes over 5 years is $195100.0, with a median of -$195500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes tumbled 1396.49% in 2022, then soared 2936.96% in 2024.
  • Year by year, Other Working Capital Changes stood at -$228000.0 in 2021, then crashed by 1396.49% to -$3.4 million in 2022, then surged by 98.74% to -$43000.0 in 2023, then tumbled by 993.02% to -$470000.0 in 2024, then skyrocketed by 60.21% to -$187000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for ATYR at -$187000.0 in Q4 2025, -$183000.0 in Q3 2025, and $1.8 million in Q2 2025.